Matthew Caufield Analyst Performance

Director, Senior Biotechnology Equity Research Analyst at HC Wainwright

Matthew Caufield is a stock analyst at HC Wainwright focused in the healthcare sector, covering 25 publicly traded companies. Over the past year, Matthew Caufield has issued 61 stock ratings, including buy and hold recommendations. While full access to Matthew Caufield's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Matthew Caufield's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
170 Last 4 Years
Buy Recommendations
88.76% 150 Buy Ratings
Companies Covered
25 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy88.8%150 ratings
Hold11.2%19 ratings
Sell0.0%0 ratings

Out of 169 total stock ratings issued by Matthew Caufield at HC Wainwright, the majority (88.8%) have been Buy recommendations, followed by 11.2% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
96.0% of companies on NASDAQ
24 companies
OTCMKTS
4.0% of companies on OTCMKTS
1 company

Matthew Caufield, an analyst at HC Wainwright, currently covers 25 companies listed on NASDAQ and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
24 companies
96.0%
Finance
1 company
4.0%

Matthew Caufield of HC Wainwright specializes in stock coverage within the Healthcare sector, with additional focus on Finance companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
15 companies
60.0%
PHARMACEUTICALS
9 companies
36.0%
FINANCIAL SERVICES
1 company
4.0%

About Matthew Caufield

Matthew Caufield is a Vice President of Equity Research at H.C. Wainwright, having joined the firm in 2018. Mr. Caufield’s research focuses on small and mid-cap biotechnology companies including innovations in the ophthalmology and gastrointestinal industries. Prior to joining H.C. Wainwright, Mr. Caufield was an Equity Research Associate at Piper Sandler & Co. assisting in the coverage of small and mid-cap biotechnology companies. Mr. Caufield previously worked as a Senior Wealth Strategy Associate in Private Wealth Management at UBS, and as an Investment Service Associate at JPMorgan Chase & Co. Mr. Caufield is a published scientist, and his educational background includes an MBA from the S.C. Johnson Graduate School of Management at Cornell University, a M.S. in Neurobiology from Northwestern University, and a B.S. in Neuroscience from Colgate University.
Follow on LinkedIn

Matthew Caufield's Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Liquidia Corporation stock logo
LQDA
Liquidia
11/13/2026Initiated Coverage$58.12$76.00Buy
Savara Inc. stock logo
SVRA
Savara
11/12/2026Initiated Coverage$4.99$10.00Buy
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
11/11/2026Boost Price Target$4.23$14.00Buy
Upstream Bio, Inc. stock logo
UPB
Upstream Bio
11/11/2026Lower Price Target$3.38$18.00Buy
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
11/9/2026Initiated Coverage$562.02$660.00Buy
Tarsus Pharmaceuticals, Inc. stock logo
TARS
Tarsus Pharmaceuticals
11/4/2026Boost Price Target$72.64$106.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
10/30/2026Reiterated Rating$6.22Buy
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
10/30/2026Lower Price Target$3.49$16.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
10/22/2026Reiterated Rating$12.62$36.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
10/13/2026Reiterated Rating$26.40$44.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
10/12/2026Boost Price Target$99.87$126.00Buy
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
10/12/2026Reiterated Rating$23.37$56.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
9/30/2026Reiterated Rating$26.76$44.00Buy
Aldeyra Therapeutics, Inc. stock logo
ALDX
Aldeyra Therapeutics
9/30/2026Reiterated Rating$1.32$2.00Neutral
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
9/28/2026Boost Price Target$87.03$96.00Buy
Surrozen, Inc. stock logo
SRZN
Surrozen
9/25/2026Reiterated Rating$33.68$54.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
9/17/2026Reiterated Rating$32.77$58.00Buy
Immunic, Inc. stock logo
IMUX
Immunic
9/10/2026Reiterated Rating$12.19$22.00Buy
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
9/9/2026Reiterated Rating$5.47$8.00Buy
Upstream Bio, Inc. stock logo
UPB
Upstream Bio
9/2/2026Reiterated Rating$6.55$36.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
8/17/2026Reiterated Rating$41.35$58.00Buy
DiaMedica Therapeutics, Inc. stock logo
DMAC
DiaMedica Therapeutics
8/11/2026Reiterated Rating$6.87$12.00Buy
Surrozen, Inc. stock logo
SRZN
Surrozen
8/10/2026Reiterated Rating$25.62$44.00Buy
Akebia Therapeutics, Inc. stock logo
AKBA
Akebia Therapeutics
8/6/2026Reiterated Rating$1.29Buy
FibroBiologics Inc. stock logo
FBLG
FibroBiologics
8/4/2026Reiterated Rating$0.79$6.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
7/31/2026Reiterated Rating$9.03$26.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
7/20/2026Reiterated Rating$10.99$36.00Buy
Tarsus Pharmaceuticals, Inc. stock logo
TARS
Tarsus Pharmaceuticals
7/9/2026Reiterated Rating$67.73$88.00Buy
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
7/7/2026Reiterated Rating$5.60Buy
Akebia Therapeutics, Inc. stock logo
AKBA
Akebia Therapeutics
7/1/2026Reiterated Rating$1.14$6.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
6/17/2026Reiterated Rating$10.43$26.00Buy
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
6/17/2026Reiterated Rating$3.90$8.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
6/3/2026Reiterated Rating$17.13Buy
Upstream Bio, Inc. stock logo
UPB
Upstream Bio
6/3/2026Initiated Coverage$7.25$36.00Buy
Upstream Bio, Inc. stock logo
UPB
Upstream Bio
6/3/2026Initiated Coverage$7.63$36.00Buy
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
6/1/2026Reiterated Rating$31.50Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
5/15/2026Reiterated Rating$18.90$44.00Buy
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
5/12/2026Lower Price Target$9.99$38.00Buy
Surrozen, Inc. stock logo
SRZN
Surrozen
5/7/2026Reiterated Rating$34.13$44.00Buy
Tarsus Pharmaceuticals, Inc. stock logo
TARS
Tarsus Pharmaceuticals
5/4/2026Reiterated Rating$63.62$88.00Buy
What the hell is going on? (Ad)

Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel

Watch Porter Stansberry's full broadcast on the coming dollar reset now
Immunic, Inc. stock logo
IMUX
Immunic
4/30/2026Reiterated Rating$10.03$22.00Buy
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
4/21/2026Lower Price Target$10.13$48.00Buy
FibroBiologics Inc. stock logo
FBLG
FibroBiologics
4/16/2026Reiterated Rating$1.51$8.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
3/27/2026Reiterated Rating$39.76$58.00Buy
Surrozen, Inc. stock logo
SRZN
Surrozen
3/24/2026Reiterated Rating$25.24$36.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
3/20/2026Reiterated Rating$8.98$36.00Buy
Aldeyra Therapeutics, Inc. stock logo
ALDX
Aldeyra Therapeutics
3/18/2026Downgrade$1.24$2.00Neutral
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
3/17/2026Reiterated Rating$23.23$44.00Buy
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
3/10/2026Set Price Target$27.10$56.00Buy
Immunic, Inc. stock logo
IMUX
Immunic
3/2/2026Lower Price Target$10.20$50.00Buy
FibroBiologics Inc. stock logo
FBLG
FibroBiologics
2/26/2026Lower Price Target$5.27$80.00Buy
Ardelyx, Inc. stock logo
ARDX
Ardelyx
2/20/2026Boost Price Target$6.74$18.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
2/10/2026Reiterated Rating$22.48$44.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
2/10/2026Reiterated Rating$24.30$38.00Buy
Immunic, Inc. stock logo
IMUX
Immunic
2/9/2026Reiterated Rating$6.20$80.00Buy
Akebia Therapeutics, Inc. stock logo
AKBA
Akebia Therapeutics
2/6/2026Reiterated Rating$1.38$6.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
1/22/2026Boost Price Target$26.71$38.00Buy
FibroBiologics Inc. stock logo
FBLG
FibroBiologics
1/2/2026Reiterated Rating$4.50$100.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
12/16/2025Reiterated Rating$32.59Buy
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
12/15/2025Reiterated Rating$18.14Buy
Akebia Therapeutics, Inc. stock logo
AKBA
Akebia Therapeutics
12/2/2025Reiterated Rating$1.51$6.00Buy
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
11/17/2025Reiterated Rating$4.29$5.00Neutral
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
11/17/2025Boost Price Target$19.51$26.00Buy
Immunic, Inc. stock logo
IMUX
Immunic
11/14/2025Lower Price Target$7.13$80.00Buy
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
11/12/2025Boost Price Target$47.11$56.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
11/11/2025Upgrade$18.49$24.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
10/31/2025Boost Price Target$13.31$26.00Buy
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
10/30/2025Boost Price Target$40.14$52.00Buy
Akebia Therapeutics, Inc. stock logo
AKBA
Akebia Therapeutics
10/30/2025Lower Price Target$2.10$6.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
10/28/2025Boost Price Target$31.80$44.00Buy
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
10/27/2025Reiterated Rating$31.86$56.00Buy
Tarsus Pharmaceuticals, Inc. stock logo
TARS
Tarsus Pharmaceuticals
10/20/2025Boost Price Target$72.93$88.00Neutral
Tarsus Pharmaceuticals, Inc. stock logo
TARS
Tarsus Pharmaceuticals
10/20/2025Reiterated Rating$72.93$88.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
10/9/2025Reiterated Rating$25.90$30.00Buy
Immunic, Inc. stock logo
IMUX
Immunic
9/26/2025Reiterated Rating$8.98$100.00Buy
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
9/23/2025Reiterated Rating$3.46$30.00Buy
FibroBiologics Inc. stock logo
FBLG
FibroBiologics
9/12/2025Reiterated Rating$11.30$200.00Buy
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
9/8/2025Reiterated Rating$34.80$42.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
8/18/2025Boost Price Target$10.57$5.00Neutral
DiaMedica Therapeutics, Inc. stock logo
DMAC
DiaMedica Therapeutics
8/15/2025Reiterated Rating$6.01$12.00Buy
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
8/14/2025Reiterated Rating$7.29Neutral
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
8/13/2025Reiterated Rating$13.51$42.00Buy
FibroBiologics Inc. stock logo
FBLG
FibroBiologics
8/5/2025Reiterated Rating$12.17$240.00Buy
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
7/28/2025Boost Price Target$31.62$48.00Buy
DiaMedica Therapeutics, Inc. stock logo
DMAC
DiaMedica Therapeutics
7/18/2025Boost Price Target$3.93$12.00Buy
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
6/27/2025Reiterated Rating$1.02$8.00Buy
Ardelyx, Inc. stock logo
ARDX
Ardelyx
6/18/2025Initiated Coverage$3.55$10.00Buy
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
6/17/2025Reiterated Rating$13.72$42.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
6/9/2025Reiterated Rating$8.92$20.00Buy
Akebia Therapeutics, Inc. stock logo
AKBA
Akebia Therapeutics
6/4/2025Initiated Coverage$3.42$8.00Buy
Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel

See the five stocks Weiss Ratings analysts are watching closely now.
DiaMedica Therapeutics, Inc. stock logo
DMAC
DiaMedica Therapeutics
5/29/2025Reiterated Rating$4.16$10.00Buy
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
5/27/2025Reiterated Rating$0.78$2.00Neutral
Tarsus Pharmaceuticals, Inc. stock logo
TARS
Tarsus Pharmaceuticals
5/27/2025Upgrade$42.98$72.00Buy
Aldeyra Therapeutics, Inc. stock logo
ALDX
Aldeyra Therapeutics
5/19/2025Reiterated Rating$2.16$10.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
5/16/2025Reiterated Rating$9.74$30.00Buy
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
5/15/2025Reiterated Rating$2.06$30.00Buy
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
5/13/2025Reiterated Rating$15.01$42.00Buy
Surrozen, Inc. stock logo
SRZN
Surrozen
5/12/2025Reiterated Rating$8.35$32.00Buy
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
5/8/2025Reiterated Rating$25.34$38.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
5/2/2025Lower Price Target$3.36$20.00Buy
Immunic, Inc. stock logo
IMUX
Immunic
5/1/2025Reiterated Rating$9.90$100.00Buy
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
4/23/2025Reiterated Rating$0.98$4.00Buy
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
4/16/2025Reiterated Rating$23.89$38.00Buy
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
4/16/2025Reiterated Rating$3.23$30.00Buy
Immunic, Inc. stock logo
IMUX
Immunic
4/15/2025Reiterated Rating$9.18$100.00Buy
Aldeyra Therapeutics, Inc. stock logo
ALDX
Aldeyra Therapeutics
4/4/2025Reiterated Rating$1.42$10.00Buy
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
4/2/2025Boost Price Target$13.84$42.00Buy
Surrozen, Inc. stock logo
SRZN
Surrozen
4/2/2025Reiterated Rating$11.12$32.00Buy
FibroBiologics Inc. stock logo
FBLG
FibroBiologics
4/1/2025Reiterated Rating$18.00$240.00Buy
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
4/1/2025Reiterated Rating$0.98$8.00Buy
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
3/31/2025Reiterated Rating$2.91$3.00Neutral
Opthea Limited Unsponsored ADR stock logo
OPT
Opthea
3/25/2025Downgrade$3.41$2.00Neutral
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
3/24/2025Lower Price Target$1.20$4.00Buy
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
3/21/2025Reiterated Rating$1.44$2.00Neutral
DiaMedica Therapeutics, Inc. stock logo
DMAC
DiaMedica Therapeutics
3/19/2025Boost Price Target$5.21$10.00Buy
Lyra Therapeutics, Inc. stock logo
LYRA
Lyra Therapeutics
3/14/2025Reiterated Rating$8.75$100.00Neutral
UNITY Biotechnology, Inc. stock logo
UBX
UNITY Biotechnology
3/10/2025Reiterated Rating$1.68$8.00Buy
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
3/10/2025Reiterated Rating$17.53$30.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
3/7/2025Reiterated Rating$5.90$28.00Buy
Aldeyra Therapeutics, Inc. stock logo
ALDX
Aldeyra Therapeutics
3/3/2025Reiterated Rating$5.11$10.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
3/3/2025Reiterated Rating$4.53$36.00Buy
Opthea Limited Unsponsored ADR stock logo
OPT
Opthea
2/28/2025Reiterated Rating$4.60$12.00Buy
Immunic, Inc. stock logo
IMUX
Immunic
2/21/2025Reiterated Rating$11.80$100.00Buy
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
2/19/2025Reiterated Rating$1.10$8.00Buy
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
2/13/2025Reiterated Rating$10.63$30.00Buy
FibroBiologics Inc. stock logo
FBLG
FibroBiologics
2/13/2025Reiterated Rating$34.60$240.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
2/10/2025Reiterated Rating$5.97$36.00Buy
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
2/6/2025Reiterated Rating$2.38$2.00Neutral
Surrozen, Inc. stock logo
SRZN
Surrozen
1/30/2025Initiated Coverage$11.25$32.00Buy
Opthea Limited Unsponsored ADR stock logo
OPT
Opthea
1/29/2025Reiterated Rating$5.00$12.00Buy
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
1/13/2025Reiterated Rating$5.52$36.00Buy
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
12/12/2024Reiterated Rating$1.20$8.00Buy
Immunic, Inc. stock logo
IMUX
Immunic
11/25/2024Initiated Coverage$11.00$100.00Buy
Hyperion DeFi, Inc. stock logo
HYPD
Hyperion DeFi
11/18/2024Downgrade$8.15$160.00Neutral